# Park Aerospace Corp: financial statements, quarterly

PKE · NYSE · CIK 76267 · [Industrials](/sectors/industrials.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/pke.md) · [Financials](/companies/pke/financials.md) · [Filings](/companies/pke/filings.md) · [Insiders](/companies/pke/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pke/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-26) | Q4 FY2024 (2024-03-03) | Q1 FY2025 (2024-06-02) | Q2 FY2025 (2024-09-01) | Q3 FY2025 (2024-12-01) | Q4 FY2025 (2025-03-02) | Q1 FY2026 (2025-06-01) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-03-01) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.6](/filings/0001437749-25-001203.md) | [16.3](/filings/0001437749-24-019951.md) | [14.0](/filings/0001437749-25-022825.md) | [16.7](/filings/0001437749-25-030897.md) | [14.4](/filings/0001437749-26-001184.md) | [16.9 d](/filings/0001437749-26-018900.md) | [15.4](/filings/0001437749-26-023883.md) | [16.4](/filings/0001437749-26-032567.md) | [17.3](/filings/0001437749-26-001184.md) | [24.2 d](/filings/0001437749-26-018900.md) | [18.3](/filings/0001437749-26-023883.md) | [20.8](/filings/0001437749-26-032567.md) |
| Cost of revenue | $m | [8.5](/filings/0001437749-25-001203.md) | [11.9 d](/filings/0001437749-26-018900.md) | [9.9](/filings/0001437749-25-022825.md) | [12.0](/filings/0001437749-25-030897.md) | [10.6](/filings/0001437749-26-001184.md) | [12.0 d](/filings/0001437749-26-018900.md) | [10.7](/filings/0001437749-26-023883.md) | [11.3](/filings/0001437749-26-032567.md) | [11.4](/filings/0001437749-26-001184.md) | [17.3 d](/filings/0001437749-26-018900.md) | [11.9](/filings/0001437749-26-023883.md) | [13.7](/filings/0001437749-26-032567.md) |
| Gross profit | $m | [3.2](/filings/0001437749-25-001203.md) | [4.5](/filings/0001437749-24-019951.md) | [4.1](/filings/0001437749-25-022825.md) | [4.8](/filings/0001437749-25-030897.md) | [3.8](/filings/0001437749-26-001184.md) | [5.0 d](/filings/0001437749-26-018900.md) | [4.7](/filings/0001437749-26-023883.md) | [5.1](/filings/0001437749-26-032567.md) | [5.9](/filings/0001437749-26-001184.md) | [6.9 d](/filings/0001437749-26-018900.md) | [6.4](/filings/0001437749-26-023883.md) | [7.1](/filings/0001437749-26-032567.md) |
| Selling, general and administrative | $m | [1.8](/filings/0001437749-25-001203.md) | [1.9 d](/filings/0001437749-26-018900.md) | [2.0](/filings/0001437749-25-022825.md) | [2.1](/filings/0001437749-25-030897.md) | [2.0](/filings/0001437749-26-001184.md) | [2.1 d](/filings/0001437749-26-018900.md) | [2.3](/filings/0001437749-26-023883.md) | [2.3](/filings/0001437749-26-032567.md) | [2.3](/filings/0001437749-26-001184.md) | [2.3 d](/filings/0001437749-26-018900.md) | [2.4](/filings/0001437749-26-023883.md) | [2.4](/filings/0001437749-26-032567.md) |
| Operating income | $m | [1.4](/filings/0001437749-25-001203.md) | [2.6 d](/filings/0001437749-26-018900.md) | [2.1](/filings/0001437749-25-022825.md) | [2.6](/filings/0001437749-25-030897.md) | [1.8](/filings/0001437749-26-001184.md) | [2.9 d](/filings/0001437749-26-018900.md) | [2.4](/filings/0001437749-26-023883.md) | [2.8](/filings/0001437749-26-032567.md) | [3.6](/filings/0001437749-26-001184.md) | [4.6 d](/filings/0001437749-26-018900.md) | [4.0](/filings/0001437749-26-023883.md) | [4.7](/filings/0001437749-26-032567.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.4](/filings/0001437749-25-001203.md) | [0.2 d](/filings/0001437749-26-018900.md) | [0.4](/filings/0001437749-25-022825.md) | [0.8](/filings/0001437749-25-030897.md) | [0.6](/filings/0001437749-26-001184.md) | [1.9 d](/filings/0001437749-26-018900.md) | [0.7](/filings/0001437749-26-023883.md) | [0.8](/filings/0001437749-26-032567.md) | [1.0](/filings/0001437749-26-001184.md) | [1.2 d](/filings/0001437749-26-018900.md) | [1.3](/filings/0001437749-26-023883.md) | [1.0](/filings/0001437749-26-032567.md) |
| Net income | $m | [1.2](/filings/0001437749-25-001203.md) | [2.7](/filings/0001437749-24-019951.md) | [1.0](/filings/0001437749-25-022825.md) | [2.1](/filings/0001437749-25-030897.md) | [1.6](/filings/0001437749-26-001184.md) | [1.2 d](/filings/0001437749-26-018900.md) | [2.1](/filings/0001437749-26-023883.md) | [2.4](/filings/0001437749-26-032567.md) | [3.0](/filings/0001437749-26-001184.md) | [3.8 d](/filings/0001437749-26-018900.md) | [3.5](/filings/0001437749-26-023883.md) | [4.5](/filings/0001437749-26-032567.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001437749-25-001203.md) | [0.13](/filings/0001437749-24-019951.md) | [0.05](/filings/0001437749-25-022825.md) | [0.10](/filings/0001437749-25-030897.md) | [0.08](/filings/0001437749-26-001184.md) | not reported | [0.10](/filings/0001437749-26-023883.md) | [0.12](/filings/0001437749-26-032567.md) | [0.15](/filings/0001437749-26-001184.md) | not reported | [0.17](/filings/0001437749-26-023883.md) | [0.21](/filings/0001437749-26-032567.md) |
| Basic EPS | $ per share | [0.06](/filings/0001437749-25-001203.md) | [0.13](/filings/0001437749-24-019951.md) | [0.05](/filings/0001437749-25-022825.md) | [0.10](/filings/0001437749-25-030897.md) | [0.08](/filings/0001437749-26-001184.md) | not reported | [0.10](/filings/0001437749-26-023883.md) | [0.12](/filings/0001437749-26-032567.md) | [0.15](/filings/0001437749-26-001184.md) | not reported | [0.17](/filings/0001437749-26-023883.md) | [0.21](/filings/0001437749-26-032567.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-11-26) | FY2024 (2024-03-03) | Q1 FY2025 (2024-06-02) | Q2 FY2025 (2024-09-01) | Q3 FY2025 (2024-12-01) | FY2025 (2025-03-02) | Q1 FY2026 (2025-06-01) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-03-01) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.2](/filings/0001437749-24-001085.md) | [6.6](/filings/0001437749-25-019023.md) | [4.1](/filings/0001437749-24-022897.md) | [8.2](/filings/0001437749-24-031340.md) | [12.8](/filings/0001437749-25-001203.md) | [21.6](/filings/0001437749-26-018900.md) | [20.6](/filings/0001437749-25-022825.md) | [29.5](/filings/0001437749-25-030897.md) | [50.5](/filings/0001437749-26-001184.md) | [78.5](/filings/0001437749-26-032567.md) | [80.5](/filings/0001437749-26-023883.md) | [98.3](/filings/0001437749-26-032567.md) |
| Current assets | $m | [93.8](/filings/0001437749-24-001085.md) | [98.8](/filings/0001437749-25-019023.md) | [97.3](/filings/0001437749-24-022897.md) | [93.0](/filings/0001437749-24-031340.md) | [92.6](/filings/0001437749-25-001203.md) | [90.3](/filings/0001437749-26-018900.md) | [87.3](/filings/0001437749-25-022825.md) | [83.3](/filings/0001437749-25-030897.md) | [84.6](/filings/0001437749-26-001184.md) | [109](/filings/0001437749-26-032567.md) | [109](/filings/0001437749-26-023883.md) | [140](/filings/0001437749-26-032567.md) |
| Total assets | $m | [128](/filings/0001437749-24-001085.md) | [132](/filings/0001437749-25-019023.md) | [129](/filings/0001437749-24-022897.md) | [125](/filings/0001437749-24-031340.md) | [124](/filings/0001437749-25-001203.md) | [122](/filings/0001437749-26-018900.md) | [121](/filings/0001437749-25-022825.md) | [116](/filings/0001437749-25-030897.md) | [118](/filings/0001437749-26-001184.md) | [142](/filings/0001437749-26-032567.md) | [144](/filings/0001437749-26-023883.md) | [175](/filings/0001437749-26-032567.md) |
| Current liabilities | $m | [6.4](/filings/0001437749-24-001085.md) | [9.7](/filings/0001437749-25-019023.md) | [7.9](/filings/0001437749-24-022897.md) | [10.2](/filings/0001437749-24-031340.md) | [12.3](/filings/0001437749-25-001203.md) | [9.3](/filings/0001437749-26-018900.md) | [10.1](/filings/0001437749-25-022825.md) | [4.7](/filings/0001437749-25-030897.md) | [5.3](/filings/0001437749-26-001184.md) | [6.0](/filings/0001437749-26-032567.md) | [7.1](/filings/0001437749-26-023883.md) | [6.2](/filings/0001437749-26-032567.md) |
| Total liabilities | $m | [15.5](/filings/0001437749-24-001085.md) | [19.4](/filings/0001437749-25-019023.md) | [17.7](/filings/0001437749-24-022897.md) | [14.9](/filings/0001437749-24-031340.md) | [16.9](/filings/0001437749-25-001203.md) | [15.0](/filings/0001437749-26-018900.md) | [15.8](/filings/0001437749-25-022825.md) | [10.7](/filings/0001437749-25-030897.md) | [11.5](/filings/0001437749-26-001184.md) | [12.3](/filings/0001437749-26-032567.md) | [13.4](/filings/0001437749-26-023883.md) | [12.4](/filings/0001437749-26-032567.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [112](/filings/0001437749-24-001085.md) | [113](/filings/0001437749-25-019023.md) | [112](/filings/0001437749-24-022897.md) | [110](/filings/0001437749-24-031340.md) | [107](/filings/0001437749-25-001203.md) | [107](/filings/0001437749-26-018900.md) | [105](/filings/0001437749-25-022825.md) | [106](/filings/0001437749-25-030897.md) | [107](/filings/0001437749-26-001184.md) | [130](/filings/0001437749-26-032567.md) | [131](/filings/0001437749-26-023883.md) | [163](/filings/0001437749-26-032567.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-26) | Q4 FY2024 (2024-03-03) | Q1 FY2025 (2024-06-02) | Q2 FY2025 (2024-09-01) | Q3 FY2025 (2024-12-01) | Q4 FY2025 (2025-03-02) | Q1 FY2026 (2025-06-01) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-03-01) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,759 d](/filings/0001437749-25-001203.md) | [5,294 d](/filings/0001437749-26-018900.md) | [(423)](/filings/0001437749-25-022825.md) | [1,446 d](/filings/0001437749-25-030897.md) | [2,725 d](/filings/0001437749-26-001184.md) | [969 d](/filings/0001437749-26-018900.md) | [1,590](/filings/0001437749-26-023883.md) | [(2,117) d](/filings/0001437749-26-032567.md) | [5,108 d](/filings/0001437749-26-001184.md) | [6,918 d](/filings/0001437749-26-018900.md) | [2,720](/filings/0001437749-26-023883.md) | [(1,450) d](/filings/0001437749-26-032567.md) |
| Capital expenditure | $k | [107 d](/filings/0001437749-25-001203.md) | [164 d](/filings/0001437749-26-018900.md) | [12.0](/filings/0001437749-25-022825.md) | [194 d](/filings/0001437749-25-030897.md) | [52.0 d](/filings/0001437749-26-001184.md) | [631 d](/filings/0001437749-26-018900.md) | [481](/filings/0001437749-26-023883.md) | [183 d](/filings/0001437749-26-032567.md) | [838 d](/filings/0001437749-26-001184.md) | [536 d](/filings/0001437749-26-018900.md) | [113](/filings/0001437749-26-023883.md) | [356 d](/filings/0001437749-26-032567.md) |
| Dividends paid | $k | [2,532 d](/filings/0001437749-25-001203.md) | [2,531 d](/filings/0001437749-26-018900.md) | [2,532](/filings/0001437749-25-022825.md) | [2,532 d](/filings/0001437749-25-030897.md) | [2,503 d](/filings/0001437749-26-001184.md) | [2,491 d](/filings/0001437749-26-018900.md) | [2,499](/filings/0001437749-26-023883.md) | [2,482 d](/filings/0001437749-26-032567.md) | [2,488 d](/filings/0001437749-26-001184.md) | [2,491 d](/filings/0001437749-26-018900.md) | [2,609](/filings/0001437749-26-023883.md) | [2,719 d](/filings/0001437749-26-032567.md) |
| Share repurchases | $k | [0.0 d](/filings/0001437749-25-001203.md) | [0.0 d](/filings/0001437749-26-018900.md) | [0.0](/filings/0001437749-25-022825.md) | [1,888 d](/filings/0001437749-25-030897.md) | [2,364 d](/filings/0001437749-26-001184.md) | [0.0 d](/filings/0001437749-26-018900.md) | [2,165](/filings/0001437749-26-023883.md) | [0.0 d](/filings/0001437749-26-032567.md) | [0.0 d](/filings/0001437749-26-001184.md) | [0.0 d](/filings/0001437749-26-018900.md) | [0.0](/filings/0001437749-26-023883.md) | [0.0 d](/filings/0001437749-26-032567.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2024 (2023-05-28) | Q2 FY2024 (2023-08-27) | Q3 FY2024 (2023-11-26) | Q4 FY2024 (2024-03-03) | Q1 FY2025 (2024-06-02) | Q2 FY2025 (2024-09-01) | Q3 FY2025 (2024-12-01) | Q1 FY2026 (2025-06-01) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.5](/filings/0001437749-24-022897.md) | [20.3](/filings/0001437749-24-031340.md) | [20.4](/filings/0001437749-25-001203.md) | [0.0](/filings/0001437749-24-019951.md) | [20.4](/filings/0001437749-25-022825.md) | [20.3](/filings/0001437749-25-030897.md) | [20.1](/filings/0001437749-26-001184.md) | [20.0](/filings/0001437749-26-023883.md) | [20.0](/filings/0001437749-26-032567.md) | [20.1](/filings/0001437749-26-001184.md) | [21.2](/filings/0001437749-26-023883.md) | [21.9](/filings/0001437749-26-032567.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,031,235 at 2026-10-05, from the cover of the [10-Q filed 2026-10-13](/filings/0001437749-26-032567.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.